44 phenotypes from 6 alleles in 11 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Etv2Gt(141.1H7)Cmhd/Etv2Gt(141.1H7)Cmhd involves: 129S1/Sv * 129X1/SvJ	abnormal dorsal aorta morphology	J:143866
	abnormal embryonic tissue morphology	J:143866
	abnormal heart development	J:143866
	abnormal vascular development	J:143866
	absent heartbeat	J:143866
	embryonic growth retardation	J:143866
	embryonic lethality during organogenesis, complete penetrance	J:143866
Etv2tm1Dlim/Etv2+ Not Specified	decreased hematopoietic stem cell number	J:172687
Etv2tm1Dlim/Etv2tm1Dlim involves: C57BL/6	abnormal blood vessel morphology	J:155850
	abnormal embryonic erythropoiesis	J:155850
	abnormal placenta development	J:155850
	abnormal placenta labyrinth morphology	J:155850
	abnormal placental labyrinth vasculature morphology	J:155850
	absent visceral yolk sac blood islands	J:155850
	absent vitelline blood vessels	J:155850
	normal cardiovascular system phenotype	J:155850
	decreased embryo size	J:155850
	embryonic growth retardation	J:155850
	embryonic lethality during organogenesis, complete penetrance	J:155850
	increased embryonic tissue cell apoptosis	J:155850
	pale yolk sac	J:155850
Etv2tm1Dlim/Etv2tm2.1Dlim Tg(Mx1-cre)1Cgn/0 involves: 129S4/SvJaeSor * C57BL/6 * CBA	abnormal hematopoietic stem cell physiology	J:172687
	abnormal myeloblast morphology/development	J:172687
	decreased bone marrow cell number	J:172687
	decreased hematopoietic stem cell number	J:172687
	decreased leukocyte cell number	J:172687
	impaired myelopoiesis	J:172687
	spleen hypoplasia	J:172687
Etv2tm1Vkou/Etv2tm1Vkou Tg(Pgk1-cre)1Lni/0 involves: BALB/c * C57BL/6	absent erythrocytes	J:194572
	absent erythroid progenitor cell	J:194572
	embryonic growth retardation	J:194572
	embryonic lethality during organogenesis, complete penetrance	J:194572
Etv2tm1Vkou/Etv2tm1Vkou Tg(Tek-cre)1Ywa/0 involves: C57BL/6 * SJL	no abnormal phenotype detected	J:194572
Etv2tm2.1Dlim/Etv2tm2.1Dlim involves: 129S4/SvJaeSor * C57BL/6	no abnormal phenotype detected	J:172687
Etv2tm2.1Nshk/Etv2tm2.1Nshk Tg(Pdgfra-cre/ERT2)1Wdr/0 involves: C57BL/6NCrlj * CBA/JNCrlj	abnormal angiogenesis	J:193389
	abnormal vitelline vasculature morphology	J:193389
	decreased hematopoietic cell number	J:193389
	decreased vascular endothelial cell number	J:193389
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+ Commd10Tg(Vav1-icre)A2Kio/Commd10+ involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj	abnormal bone marrow cell morphology/development	J:203163
	abnormal hematopoietic system morphology/development	J:203163
	anemia	J:203163
	decreased common myeloid progenitor cell number	J:203163
	decreased erythroid progenitor cell number	J:203163
	preweaning lethality, incomplete penetrance	J:203163
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+ Tg(Tek-cre)1Ywa/0 involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL	abnormal definitive hematopoiesis	J:203163
	abnormal vitelline vasculature morphology	J:203163
	embryonic lethality during organogenesis, incomplete penetrance	J:203163
	hemorrhage	J:203163
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+ Meox1tm1(cre)Jpa/Meox1+ involves: C57BL/6NCrlj * CBA/JNCrlj	no abnormal phenotype detected	J:203163
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+ Sox1tm1(cre)Take/Sox1+ involves: C57BL/6NCrlj * CBA/JNCrlj	normal cardiovascular system phenotype	J:203163
	normal embryo phenotype	J:203163
	normal hematopoietic system phenotype	J:203163
	normal mortality/aging	J:203163
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+ Sox17tm1(icre)Heli/Sox17+ involves: 129S2/SvPas * C57BL/6NCrlj * CBA/JNCrlj	normal embryo phenotype	J:203163
	normal mortality/aging	J:203163
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata involves: C57BL/6NCrlj * CBA/JNCrlj	no abnormal phenotype detected	J:203163